Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Infections

Explore clinical trials studying Meningococcal Infections. Study availability and eligibility vary by location and protocol.

216 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Infections trial results

Completed

Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects.

NCT02141516

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +13 more
Locations
  • 12, Novartis Investigational Site Florence, Italy
  • 11, Novartis Investigational Site Genova, Italy
  • 10, Novartis Investigational Site Milan, Italy
  • 14, Novartis Investigational Site Padova, Italy
View all 20 locations
View Trial Details
Completed

Phase 2, Observer-Blind, Placebo-Controlled, Randomized, Multi-Center Extension Study to Evaluate the Safety and Immunogenicity of a Booster Dose of a MenABCWY Vaccine Administered 24 Months Following the Primary Series to Adolescents and Young Adults Who Participated in V102_03 (NCT01272180)

NCT01992536

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Site 23, Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615 Birmingham, Alabama, United States
  • Site 24, Madera Family Medical Group 1111 West 4th Street Madera, California, United States
  • Site 25, Center for Clinical Trials LLC 16660 Paramount Blvd, Suite 301 Paramount, California, United States
  • Site 28, Kentucky Pediatric/Adult Research 201 South 5th Street Bardstown, Kentucky, United States
View all 13 locations
View Trial Details
Completed

Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine

NCT00126984

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Guessing, Austria
  • GSK Investigational Site Neufeld/Leitha, Austria
  • GSK Investigational Site Salzburg, Austria
  • GSK Investigational Site Villach, Austria
View all 42 locations
View Trial Details

Related conditions